No Survival Benefit With T-VEC in Advanced Melanoma
Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
All articles by Leah Lawrence
Many Sponsors Don’t Share Data From Trials Supporting Cancer Drug Approvals
Many clinical trials supporting cancer drug approvals are ineligible for individual participant data sharing, a new study suggests.
USPSTF: Do Not Take Vitamin E, Beta Carotene to Prevent Cancer
Vitamin E does not decrease the risk of cancer or cancer-related death, and the risk of harm from beta carotene outweighs any potential benefits, according to the USPSTF.
New Cancer Diagnosis Linked to Increased Risk of Cardiovascular Death
A new cancer diagnosis is independently associated with a higher risk of cardiovascular death, stroke, heart failure, and pulmonary embolism.
1 in 5 Cancer Patients on Phase 3 Trials Use Complementary Medicine
The most common complementary medicines were herbal/natural products, dietary supplements, fish oils, glucosamine, and homeopathic medicines.
Study Supports Cervical Cancer Screening After Age 65
About 63% of patients were diagnosed with stage II or higher disease.
Genomic-Based Targeted Therapy Improved PFS for Certain Metastatic Breast Cancers
The researchers found that targeted therapies matched to genomic alterations in ESCAT tier I/II significantly improved progression-free survival.
Most NCCN Radiotherapy Recommendations Not Backed by High-Level Evidence
Less than 10% of radiotherapy recommendations in 2020 NCCN guidelines were category 1 recommendations.
Pandemic-Related Delays in Cancer Surgery May Not Affect Short-Term Outcomes
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays.
Changes in BMI, Weight Linked to Survival in Endometrial Cancer
Changes in weight and BMI were associated with disease-free and overall survival.
- Loading...
Loading...
Loading... 
Loading...